Endothelial MICU1 protects against vascular inflammation and atherosclerosis by inhibiting mitochondrial calcium uptake

Lu Sun (Co-first Author), Ruixue Leng (Co-first Author), Monan Liu, Meiming Su, Qingze He, Zhidan Zhang, Zhenghong Liu, Zhihua Wang, Hui Jiang, Li Wang, Shuai Guo, Yiming Xu, Yuqing Huo, Clint L. Miller, Maciej Banach, Yu Huang, Paul C. Evans, Jaroslav Pelisek, Giovanni G. Camici, Bradford C. BerkStefan Offermanns, Junbo Ge, Suowen Xu*, Jianping Weng*

*Corresponding author for this work

Research output: Journal Publications and ReviewsRGC 21 - Publication in refereed journalpeer-review

2 Citations (Scopus)
11 Downloads (CityUHK Scholars)

Abstract

Mitochondrial dysfunction fuels vascular inflammation and atherosclerosis. Mitochondrial calcium uptake 1 (MICU1) maintains mitochondrial Ca2+ homeostasis. However, the role of MICU1 in vascular inflammation and atherosclerosis remains unknown. Here, we report that endothelial MICU1 prevents vascular inflammation and atherosclerosis by maintaining mitochondrial homeostasis. We observed that vascular inflammation was aggravated in endothelial cell–specific Micu1 knockout mice (Micu1ECKO) and attenuated in endothelial cell–specific Micu1 transgenic mice (Micu1ECTg). Furthermore, hypercholesterolemic Micu1ECKO mice also showed accelerated development of atherosclerosis, while Micu1ECTg mice were protected against atherosclerosis. Mechanistically, MICU1 depletion increased mitochondrial Ca2+ influx, thereby decreasing the expression of the mitochondrial deacetylase sirtuin 3 (SIRT3) and the ensuing deacetylation of superoxide dismutase 2 (SOD2), leading to the burst of mitochondrial reactive oxygen species (mROS). Of clinical relevance, we observed decreased MICU1 expression in the endothelial layer covering human atherosclerotic plaques and in human aortic endothelial cells exposed to serum from patients with coronary artery diseases (CAD). Two-sample Wald ratio Mendelian randomization further revealed that increased expression of MICU1 was associated with decreased risk of CAD and coronary artery bypass grafting (CABG). Our findings support MICU1 as an endogenous endothelial resilience factor that protects against vascular inflammation and atherosclerosis by maintaining mitochondrial Ca2+ homeostasis. © 2025, Sun et al.
Original languageEnglish
Article numbere181928
JournalJournal of Clinical Investigation
Volume135
Issue number7
Online published1 Apr 2025
DOIs
Publication statusPublished - 1 Apr 2025

Funding

The authors thank the researchers and institutions who shared their data and all participants involved in this study. We also want to acknowledge the participants and investigators of the FinnGen study. This study was supported by grants from the National Key R&D Program of China (grant no. 2021YFC2500500), the National Natural Science Foundation of China (grant nos. 82003741, 82070464, 82370444, 12411530127), USTC Research Funds of the Double First-Class Initiative (YD9110002089), and the Hong Kong Research Grants Council (grant T12-101/23-N, SRFS2021-4S04). This work was also supported by the Program for Innovative Research Team of The First Affiliated Hospital of USTC (CXGG02) and the Anhui Provincial Natural Science Foundation (grant no. 2208085J08). PCE was supported by the British Heart Foundation (RG/19/10/34506). PCE made a significant contribution to analyzing and interpreting the data and reviewed the manuscript for important intellectual content. SX is a recipient of a Humboldt Research Fellowship from the Alexander von Humboldt Foundation, Germany.

Publisher's Copyright Statement

  • This full text is made available under CC-BY 4.0. https://creativecommons.org/licenses/by/4.0/

Fingerprint

Dive into the research topics of 'Endothelial MICU1 protects against vascular inflammation and atherosclerosis by inhibiting mitochondrial calcium uptake'. Together they form a unique fingerprint.

Cite this